IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
Condition: Metastatic Uveal Melanoma Interventions: Drug: IDE196; Drug: Crizotinib; Drug: Pembrolizumab; Drug: Ipilimumab; Drug: Nivolumab; Drug: Dacarbazine Sponsor: IDEAYA Biosciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials